788
CHEMISTRY & BIODIVERSITY – Vol. 9 (2012)
ˇ
[17] C. Ochi, N. Norisada, M. Moriguchi, A. Stalc, U. Urleb, S. Muraoka, Arzneim. Forsch./Drug Res.
1999, 49, 72.
ˇ ˇ
ˇ
[18] S. Gobec, M. Sollner-Dolenc, U. Urleb, B. Wraber, S. Simcic, M. Filipic, Farmaco 2004, 59, 345.
ˇ ´ ˇ ´
[19] B. Vranesic, J. Tomasic, S. Smerdel, D, Kantoci, F. Benedetti, Helv. Chim. Acta 1993, 76, 1752.
ˇ ´
ˇ ´
´
ˇ
[20] B. Vranesic, J. Tomasic, ꢅ. Ljevakovic, I. Hrsak, in ꢄImmunotherapy of Infectionꢀ, Ed. N. Masihi,
Marcel Dekker, New York, Basel, Hong Kong, 1994, 241.
ˇ ´
´
ˇ ´
´
ˇ ´
[21] G. Dasic, S. Rabatic, B. Vranesic, J. Tomasic, Period. Biol. 1996, 98, 319.
ˇ
ˇ
ˇ ´
´
ˇ ´
[22] R. Mazuran, B. Vranesic, M. Ikic-Sutlic, D. Simrak, J. Tomasic, Period. Biol. 1996, 98, 305.
ˇ
ˇ
ˇ ´
´
ˇ ´
ˇ ´
[23] J. Tomasic, I. Hanzl-Dujmovic, B. Spoljar, B. Vranesic, M. Santak, A. Jovicic, Vaccine 2000, 18, 1236.
ˇ ´
[24] L. Habjanec, B. Halassy, J. Tomasic, Int. Immunopharmacol. 2010, 10, 751.
[25] D. T. Oꢀ Hagan, E. De Gregorio, Drug Discovery Today 2009, 13, 541.
[26] A. M. Harandi, D. Medaglini, R. J. Shattock, Vaccine 2010, 28, 2363.
[27] P. H. Seidl, K. H Schleifer, ꢄBiological Properties of Peptidoglycansꢀ, Walter de Gruyter, Berlin,
1986.
[28] F. Ellouz, A. Adam, R. Ciorbaru, E. Lederer, Biochem. Biophys. Res. Commun. 1974, 59, 1317.
[29] G. M. Bahr, L. Chedid, FASEB J. 1986, 45, 2541.
ˇ ´
´
ˇ ´
ˇ ´
[30] B. Vranesic, ꢅ. Ljevakovic, J. Tomasic, B. Ladesic, Clin. Chim. Acta 1991, 202, 23.
ˇ
ˇ
´
ˇ ´
´
[31] ꢅ. Ljevakovic, J. Tomasic, V. Sporec, B. Halassy Spoljar, I. Hanzl-Dujmovic, Bioorg. Med. Chem.
2000, 8, 2441.
´
´
ˇ ´
[32] R. Ribic, L. Habjanec, M. Brgles, S. Tomic, J. Tomasic, Bioorg. Med. Chem. 2009, 17, 6096.
[33] M. A. V. Gianan, E. S. Kleinerman, Cancer Biother. Radiopharm. 1998, 13, 363.
ˇ ´
´
ˇ ´
[34] R. Frkanec, V. Noethig-Laslo, B. Vranesic, K. Mirosavljevic, J. Tomasic, Biochim. Biophys. Acta
2003, 1611, 187.
ˇ
ˇ
´
´
ˇ ´
[35] R. Frkanec, D. Travas, M. Krstanovic, B. Halassy Spoljar, ꢅ. Ljevakovic, B. Vranesic, L. Frkanec, J.
ˇ ´
Tomasic, J. Liposome Res. 2003, 13, 279.
[36] P. Lefrancier, E. Bricas, Bull. Soc. Chem. Biol. 1967, 49, 1257.
[37] G. Han, M. Tamaki, V. J. Hruby, J. Pept. Res. 2001, 58, 338.
[38] F. S. Gibson, S. C. Bergmeier, H. Rapoport, J. Org. Chem. 1994, 59, 3216.
[39] J. E. Sheppeck II, H. Kar, H. Hong, Tetrahedron Lett. 2000, 41, 5329.
´
´
˜
[40] J. Clariana, S. Garcꢆa-Granda, V. Gotor, A. Gutierrez-Fernandez, A. Luna, M. Moreno-Manas, A.
Vallribera, Tetrahedron: Asymmetry 2000, 11, 4549.
[41] A. Baskakova, W. Frey, V. Jꢇger, Synthesis 2010, 21, 3693.
[42] K. Shreder, L. Zhang, M. Goodman, Tetrahedron Lett. 1998, 39, 221.
[43] T. Barman, in ꢄEnzyme Handbookꢀ, Springer-Verlag, Berlin, Heidelberg, New York, 1969, Vol. 1,
p. 176.
[44] H. C. Yip, A. Y. Karulin, M. Tary-Lehman, M. D. Hesse, H. Radeke, P. S. Heeger, J. Immunol. 1999,
162, 3942.
[45] X. P. Ioannou, S. M. Gomis, B. Karvonen, R. Hecker, L. A. Babiuk, S. van Drunen Little-van den
Hurk, Vaccine 2002, 21, 127.
´
ˇ ´
ˇ ´
[46] D. Keglevic, B. Ladesic, J. Tomasic, Z. Valinger, R. Naumski, Biochim. Biophys. Acta 1979, 585, 273.
ˇ
ˇ ´
[47] B. Gaspert, S. Hromadko, B. Vranesic, Croat. Chem. Acta 1976, 48, 169.
ˇ ´
[48] L. Habjanec, R. Frkanec, B. Halassy, J. Tomasic, J. Liposome Res. 2006, 16, 1.
´
ˇ ´
[49] B. Halassy, M. Krstanovic, R. Frkanec, J. Tomasic, Vaccine 2003, 21, 971.
Received April 8, 2011